Esperion Therapeutics, Inc. (16) | Business Operations (3)
- 1st Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated June 18, 2020 (Filed With SEC on August 10, 2020)
- License and Collaboration Agreement by and between the Registrant and Otsuka Pharmaceutical Co., Ltd. dated April 17, 2020 (Filed With SEC on August 10, 2020)
- License and Collaboration Agreement by and between Daiichi Sankyo Europe GmbH and the Company, dated as of January 2, 2019 (Filed With SEC on February 28, 2019)